Last updated on July 2020

ME-401 in Subjects With Follicular Lymphoma After Failure of Two or More Prior Therapies (TIDAL)


Brief description of study

This is the study of the PI3K inhibitor ME-401 in subjects with relapsed/refractory follicular lymphoma after failure of at least 2 prior lines of systemic therapy

Detailed Study Description

This is a global, multicenter open-label, single-arm, Phase 2 study of the PI3K inhibitor ME-401 in subjects with relapsed/refractory follicular lymphoma after failure of at least 2 prior lines of systemic therapy which must have included an anti-CD20 antibody and chemotherapy with an alkylating agent or a purine analogue.

Approximately 120 subjects will be enrolled and treated with ME-401 on the intermittent schedule.

Clinical Study Identifier: NCT03768505

Find a site near you

Start Over

Renovatio Clinical

Houston, TX United States
  Connect »

Swedish Cancer Institute

Seattle, WA United States
  Connect »

Memorial Sloan Kettering

New York, NY United States
  Connect »

North Shore Hospital

Auckland, New Zealand
  Connect »

Cleveland Clinic Foundation

Cleveland, OH United States
  Connect »

Stony Brook University

Stony Brook, NY United States
  Connect »

Cleveland Clinic

Cleveland, OH United States
  Connect »

Dong-A University Hospital

Busan, Korea, Republic of
  Connect »

Asan Medical Center

Seoul, Korea, Republic of
  Connect »

Clinical Research Alliance

Lake Success, NY United States
  Connect »

Vanderbilt University

Nashville, TN United States
  Connect »

CHD Vendee, Onco-hematologie

La Roche-Sur-Yon Cedex 9, France
  Connect »

Samsung Medical Center

Seoul, Korea, Republic of
  Connect »

Ulsan University Hospital

Ulsan, Korea, Republic of
  Connect »

Royal Marsden Hospital

London, United Kingdom
  Connect »

St George's Hospital

London, United Kingdom
  Connect »

Sharp Memorial Hospital

San Diego, CA United States
  Connect »

Cleveland Clinic-Florida

Weston, FL United States
  Connect »

Royal Hallamshire Hospital

Sheffield, United Kingdom
  Connect »

Marshfield Medical Center

Marshfield, WI United States
  Connect »

San Juan Oncology

Farmington, NM United States
  Connect »

Memorial Sloan Kettering

Basking Ridge, NJ United States
  Connect »

Memorial Sloan Kettering

Middletown, NJ United States
  Connect »

Memorial Sloan Kettering

Montvale, NJ United States
  Connect »

Memorial Sloan Kettering

Commack, NY United States
  Connect »

Memorial Sloan Kettering

Harrison, NY United States
  Connect »

Memorial Sloan Kettering

Uniondale, NY United States
  Connect »

Swedish Cancer Institute

Edmonds, WA United States
  Connect »

Royal Cornwall Hospital

Cornwell, United Kingdom
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.